NL-OMON49141
Completed
N/A
*A pilot study to assess the safety and feasibility of fluorescent sentinel lymph node identification in colon carcinoma using Indocyanine green and nanocolloid* - FLUOR*ICG*SLN(pilot)
Meander Medisch Centrum0 sites10 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- colon carcinoma
- Sponsor
- Meander Medisch Centrum
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Oral and written informed consent (IC)
- •\- Aged 18 years and older
- •\- Pathologically confirmed and/or suspected colon carcinoma
Exclusion Criteria
- •\- Distant metastases
- •\- Suspicion of T3\-T4 disease based on pre\-operative assessment.
- •\- Metastatic or T4 disease discovered during intraoperative staging
- •\- A tumour too large to pass endoscopically
- •\- Pregnant patients
- •\- Known allergy to any of the compound used for SLN identification (ICG, Iodine)
- •\- Suspected or proven lymph node metastasis
- •\- Previous colon surgery
- •\- Contra\-indication for robotic surgery
- •\- Ink marking close to the tumour
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
Identification of the sentinel lymph node (SLN) in patients with colon carcinoma.Colon carcinomaTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]EUCTR2019-003179-20-NLMeander Medical Centre10
Recruiting
Phase 1
A pilot study of patients with oligometastases from breast cancer treated with stereotactic ablative body radiosurgery in combination with the anti-PD-1 antibody MK-3475.Metastatic Breast Cancer (1-5 metastases)Cancer - BreastCancer - BoneACTRN12614001181695Peter MacCallum Cancer Centre15
Recruiting
N/A
A pilot study to assess the safety and feasibility of fluorescent sentinel lymph node identification in colon carcinoma using Indocyanine green.NL-OMON24349Meander Medical Centre, Department of Surgery10
Active, Not Recruiting
Phase 1
Identification of the sentinel lymph node (SLN) in patients with colon carcinoma.Colon carcinomaTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]EUCTR2021-006796-41-NLMeander Medical Centre5
Completed
N/A
A pilot study to assess the safety and feasibility of fluorescent sentinel lymph node identification in colon carcinoma using intravenous bevacizumab-800CWcolon carcinomaintestinal cancer1001799010017991NL-OMON53524Meander Medisch Centrum5